N/A
N=10
Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Exercise Performance in Humans.
Alcohol Intake · Sleep Deprivation
Bottom Line
View on ClinicalTrials.gov: NCT02117193 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Sep 2016
Primary outcome: Primary: Aerobic Performance — 172; 173; 175; 176 bpm
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Alcohol intake (Other); Sleep deprivation (Other)
- Age
- Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Federal University of Rio Grande do Sul
- Primary completion
- May 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Aerobic Performance |
172; 173; 175; 176 | — |
| PRIMARY Neuromuscular Performance |
260.8; 242.3; 258.9; 249.5 | — |
| PRIMARY Biochemical Responses |
89.82; 84.76; 92.77; 92.85 | — |
| SECONDARY Hydration Status |
1.017; 1.017; 1.015; 1.011 | — |
| SECONDARY Profile of Mood States |
— | — |
| SECONDARY Breath Alcohol |
— | — |
Summary
Although the effects of acute alcohol intake and sleep deprivation on exercise performance lacks evidence in the literature, in many situations, they occur simultaneously. Once the alcohol affects physiological processes, the processes that occur during sleep can be impaired, such as: suppression of GH release, action of neurotransmitters and neuromodulators in the CNS, changes in the proportion of sleep stages and may lead to suppression of REM sleep. These changes promote a significant functional impairment such as a reduction in alertness and modification in reaction time, which affects the performance of any activity of daily and professional life. However, the combined effects on the physical performance variables, such as aerobic and neuromuscular performance lack of evidence in the literature.
Eligibility Criteria
Inclusion Criteria
- Physical active men
Exclusion Criteria
- AUDIT questionnaire above 15 points
- Nocturnal Chronotype
- Skeletal muscle injuries in upper and lower limb
- Metabolic and cardiovascular disease
Data sourced from ClinicalTrials.gov (NCT02117193). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.